Findings from a small study suggest it could be an effective, safe, and attractive alternative to fluoroquinolones, bacterial resistance to which is becoming increasingly prevalent.
Men with Peyronie's disease have elevated risks of benign prostatic hyperplasia, prostatitis, and testis and prostate cancer, new studies reveal.
CBP was associated with a reduction in sperm concentration, sperm vitality, sperm total and progressive motility.
Imaging studies should be considered for men who have long symptom duration and voiding disturbances associated with acute prostatitis, researchers say.
Case presented of patient with extended-spectrum beta-lactamase E. coli infection.
In white men, the condition is associated with an increased risk of prostate cancer only in the absence of histologic inflammation.
No correlations seen in large cohort study of U.S. male health professionals.
Physicians face an increasing prevalence of chronic bacterial prostatitis cases that are resistant to fluoroquinolones, which have been a mainstay of treatment.
The biomarkers PHI and PCA3 demonstrated high diagnostic accuracy in discriminating prostate cancer from prostatitis in re-biopsy candidates.
Researchers observe no association between prostate cancer and urethritis, orchitis, or epididymitis.
Periodontal problems linked to inflammation throughout the body, researcher says.
Patients experienced significant improvements in symptoms and quality of life parameters.
The condition is more likely in men with chronic bacterial prostatitis caused by C. trachomatis rather than other uropathogens.
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) may put men at increased risk for colorectal cancer, a study found. The association was most prominent among men younger than 60 years.
Researchers in Egypt have found an "alarmingly high" rate of acute prostatitis following prostate biopsy and identified prior fluoroquinolone use as a significant risk factor for its development, according to a report in Urology.
Etiology and treatment are clearly defined for infectious prostatic syndromes, but not for chronic pelvic pain syndrome.
WASHINGTON, D.C.—Silodosin may be an effective treatment for moderate or severe chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), researchers reported at the American Urological Association 2011 annual meeting.
Most of Dr. W's cases were referrals from other physicians, often from physicians with whom he was friends.
Men with the most severe form of prostatitis also showed signs of periodontitis, raising the possibility that the inflammation characterizing the two conditions may be related.
SAN FRANCISCO—Dutasteride treatment may decrease prostatitis-related symptoms, data suggest.
The condition can be challenging to diagnose because it frequently refers to a vague constellation of pelvic pain and voiding symptoms.
Patients with chronic prostatitis have a higher prevalence of seropositivity to Helicobacter pylori compared with patients without the condition, according to researchers.
A pollen extract may be an effective treatment for inflammatory chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), a German study suggests.
Electroacupunture (EA) may be an effective way to relieve pain in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), according to Korean investigators.
Long-term antibiotic therapy for men with biopsy-proven asymptomatic prostatitis may not significantly alter elevated PSA levels, data show.
Physician-diagnosed prostatitis is associated with 2.4-fold increased risk of a later diagnosis of BPH and a 70% increased risk of requiring later treatment for that condition, according to a study published in Urology (2008;71:475-479).
Acupuncture may ease symptoms of chronic prostatitis/chronic pelvic pain (CP/CPPS), according to a report in The American Journal of Medicine (2008;121:79.e1-79.e7).
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)